Hindustan Times (Lucknow)
‘New inhalable drug to replace traditional insulin’
Afrezza drug, an inhalable insulin, is going to play a vital role in replacing injectable insulin
LUCKNOW: Prominent diabetes expert Dr AK Tiwari of Jai clinic said that during the current year there would be a major breakthrough in the treatment of the disease. Dr Tiwari claimed the development of Afrezza drug, an inhalable insulin was going to play a vital role in replacing traditional injectable insulin.
In a statement on the occa- sion of World Diabetes Day on Saturday (November 14), Dr Tiwari said new technology had introduced a fresh dimension in the treatment of the disease. He said Afrezza inhaler drug was available in the US market and it was an ultra short-acting insulin to be taken at meal time.
Dr Tiwari said this inhalable insulin would reduce the number of traditional insulin intake.
However, he said this new drug was not advisable for those suffering from respiratory problems and for smokers. Moreover, it could also not be taken by patients below the age of 18 years. He said the second major development was arrival of ‘free style libre flash glucose monitoring system’ that was available in the Indian market. Under this therapy, a sensor is attached to the hand of the patient that continuously monitors blood sugar level for 14 days.
After 14 days, the device provides a detailed analysis of blood sugar level of the patient. Dr Tiwari said it was cheaper than the available continuous glucose monitoring system. He said with the availability of several effective drugs, the management of diabetes had become easy in the country.
DR AK TIWARI, Jai Clinic